ALA is backed by Merchant Funds Management, whose manager Andrew Chapman has an impressive track record in biotech investing.
His most notable success are:
- Polynovo: $0.04 to $2.30 ($4.05 high) – 10,025% (return low to high)
- BARD1 Life Sciences: $0.50 to $1.45 ($5.60 high) – 1,020% (return low to high)
- Race Oncology: $0.14 to $3.35 ($4.20 high) – 2,900% (return low to high)
Ann: Trading Halt, page-58
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $162.8M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 15.5¢ | $163.5K | 1.045M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 333789 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 170000 | 2 |
View Market Depth
| Last trade - 15.55pm 03/07/2024 (20 minute delay) ? |
| ALA (ASX) Chart |